Medigrowth International
Mehrauli, New Delhi, Delhi
GST No.
07CAGPS9340P1ZV
TrustSEAL
Verified
Call 08048972783
91% Response Rate
SEND EMAIL
Our Products
»
Anti Cancer Medicine
Cancer Treatment Tablets Manufacturer In China
Anti Cancer Tablets
Anti Cancer Medicines
Pharmaceutical Injection
Bevacizumab
Anti Cancer Injection
Pharmaceutical Capsules
Pharmaceutical Tablets
Anticancer Injection
Paclitaxel Injection Ip
Anti Cancer Drug
Oncology Injections
Hiv- Aids Medicines
Cancer Injections
Revolade Tablets
Anti Cancer Tablet And Injection
Anti Cancer
Hepeatitis C Medicine
Antifungal
Transplant Medicine
Anti Viral Drugs
Xgeva Injection
Immunoglobulin
Sanitinib Malate Capsules
Gemcitabain
Nutritional Supplements
Antiviral Drugs
CORONA MEDICINE
Reverse Osmosis Membrane
Docetaxel Injection
Rituximab
Pulse Oximeter Machine
Posaconazole Oral Suspension
Pulse Oximeter
Entecavir Tablet
Zinc Tablet
Dexlansoprazole
Oxaliplatin Injections
Pharmaceuticals Injectables And Anti Cancer Medicines
Corona Test Kit
Infusions And Injections
New Items
Home
Profile
»
Testimonial
Download Brochure
Contact Us
Home
»
Our Products
»
Nutritional Supplements
NUTRILITE
Nutrilite
Get Best Quote
Approx. Price:
Rs 800
/ Bottle
Get Latest Price
Product Details:
Form
Powder
Country of Origin
Made in India
Nutrilite protein powder is used to supplement a diet with extra protein to support muscle growth, overall health, and repair and maintenance of tissues.
Request
Callback
Yes! I am Interested
X
Product Videos
Cizumab 400 Mg Bevacizumab Injection
Get Best Quote
Cizumab 100 mg Bevacizumab Injection
Get Best Quote
Explore More Products
Glivec 400 Mg Tablet
Get Best Quote
Cladrim 10mg Injection
Get Best Quote
Versavo 100mg /4ml Bevacizumab Injection
Get Best Quote
Ujvira 160mg inj.
Get Best Quote
E Vir 0.5mg Tablets
Get Best Quote
Pulse Oximeters
Get Best Quote
View All Products
Reach Us
REEMA SINGH (CEO)
Medigrowth International
UGF- 03, Plot No. 891/8, Kalka Das Marg
Mehrauli, New Delhi - 110030, Delhi, India
Get Directions
Call Us
Call Response Rate: 91%
Share Us
Facebook
Twitter
LinkedIn
Send E-mail